Shelter Pharma Ltd IPO: Issue Details, Open/Close Date | Research 360 by Motilal Oswal
Back arrow

Shelter Pharma

CMP

51.50

+1.40 (2.79%)

₹42

Offer Price

₹ 16.03 Cr

Issue Size

₹ 1,26,000

Min Investment

3,000

Lot size

Time Line

  • 10
    Aug 2023
    Open
  • 14
    Aug 2023
    Close
  • 21
    Aug 2023
    Finalisation of Basis of Allotment
  • 22
    Aug 2023
    Initiation of Refunds
  • 23
    Aug 2023
    Transfer of Shares to Demat Account
  • 23
    Aug 2023
    Listing Date

Objects of the Offer

  • Focus on Increase in Volume of Sales.

  • Increasing the number of Clients.

  • Building-up as a Professional Organisation.

  • Continue to attract and retain talent.

Products & Services

  • The Company primarily focuses in manufacturing herbal products with well-built presence in Human Pharma as well as Veterinary space.

Strengths

  • Experienced Promoters and Management Team.

  • Scalable Business Model.

  • Wide and Diverse Range of Product Offering.

  • Marketing & Branding Efforts.

  • Focus on Increase in Volume of Sales.

Risks

  • There are outstanding legal proceedings involving the Company, its Group Entity, Promoters and Directors. Any adverse decision in such proceeding may have a material adverse effect on its business, results of operations and financial condition.

  • The Company was classified as a `Defaulter` by CIBIL and `Wilful Defaulter` by Watchout Investors for the default committed in the year 2016.

  • Being a pharmaceutical company, the company operate in a highly regulated and controlled industry environment. Its business is dependent on approvals from relevant regulatory and health authorities. Any delay or failure to obtain or renew such required regulatory approvals, registrations or any change in the regulatory environment in relation to marketing its products in regulated markets may significantly impact the company business and strategy affecting its overall profitability.

  • The company business requires it to obtain and renew certain registrations, licenses and permits from government and regulatory authorities and the failure to obtain and renew them in a timely manner may adversely affect its business operations.

  • The company business largely depends on the performance of its distributors. Any non-performance by these distributors may adversely affect the company business operations, profitability and cash flows.

Company Promoters

Promoters Holding

Issue For IPO
13.71%
Pre Holding

41.53%

Post Holding

27.82%

Top Promoters Holding

Financials

All values in Cr

Mar-2022 Mar-2023 Mar-2023 3-Yr trend
Revenue 30.06 (33.70%) 36.15 (20.30%) 39.86 (-)
Gross Profit 30.06 (33.70%) 36.15 (20.30%) 39.86 (-)
Net Income 30.06 (33.70%) 36.15 (20.30%) 39.86 (-)
Assets 30.06 (33.70%) 36.15 (20.30%) 39.86 (-)
Liabilities 30.06 (33.70%) 36.15 (20.30%) 39.86 (-)

Peers

Company Name Revenue (Cr) Net Profit (Cr) Assets (Cr) Liabilities (Cr) ROE EPS BVPS Current Ratio Debt to Assets
Shelter Pharma Ltd 36.15 5.78 16.34 1.83 39.86 0.00 17.52 3.66 0.11
Dabur India Ltd 11,529.89 1,707.15 13,654.37 13,654.37 19.02 9.61 53.29 12.50 0.11
Emami Ltd 3,405.73 639.57 3,109.85 3,109.85 27.77 14.50 52.43 20.56 0.03

Book Running Managers

  • Gretex Corporate Services Ltd

Registrar & Transfer Agent

Bigshare Services Pvt Ltd

Office No 56-2,
Pinnacle Busine.Park,
Mahakali Caves Road - Mumbai - 400093
Phone : 91-22-62638200 Fax: 91-22-63638299

Company Contact Information

Shelter Nagar,
Near S T Bus Stand,
Himmatnagar - 383001
Phone : 91-0277-2296038 Email : info@shelter.co.in www.shelter.co.in

Offer Related Information

Public issue of 38,16,000 equity shares of face value of Rs. 10.00 each ("Equity Shares") of Shelter Pharma Limited (the "Company" or the "Issuer") for cash at a price of Rs. 42.00 per equity share including a share premium of Rs. 32.00 per equity share (the "Issue Price") aggregating to Rs. 16.03 crores ("The Issue") of which 1,92,000 equity shares of face value of Rs. 10.00 each for cash at a price of Rs. 42.00 per equity share including a share premium of Rs. 32.00 per equity share... More

Take your research to the next level.
Login now to unlock Exclusive Features!

Take your research to the next level.
Login now to unlock Exclusive Features!

Download Our App On: